⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for peposertib 100 mg

Every month we try and update this database with for peposertib 100 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Peposertib in Combination With Capecitabine and RT in Rectal CancerNCT03770689
Locally Advance...
Peposertib 50 m...
Peposertib 100 ...
Peposertib 150 ...
Peposertib 250 ...
Capecitabine
Radiotherapy (R...
18 Years - EMD Serono
Study of Peposertib in Combination With Capecitabine and RT in Rectal CancerNCT03770689
Locally Advance...
Peposertib 50 m...
Peposertib 100 ...
Peposertib 150 ...
Peposertib 250 ...
Capecitabine
Radiotherapy (R...
18 Years - EMD Serono
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: